APO RESEARCH · REPORT
Covid Testing Kit
COVID-19 testing involves analysing samples that indicate the present or past presence of SARS-CoV-2. The two main branches detect either the presence of the virus or antibodies produced in response to infection.
Product & engineering
Understand the product.
COVID-19 testing involves analysing samples that indicate the present or past presence of SARS-CoV-2. The two main branches detect either the presence of the virus or antibodies produced in response to infection.
Tests for viral presence are used to diagnose illness and to allow public health authorities to identify and contain outbreaks as quickly as possible. Antibody tests instead support attempts to estimate the prevalence of disease within a population. Another, speculative use is to identify individuals who the antibodies have rendered immune to the disease, although research has yet to confirm that a positive test confers such immunity.
Individual jurisdictions have adopted a broad range of testing protocols. They vary in choosing whom to test, how often to test, analysis protocols, sample collection and the uses of test results. This variation has likely significantly impacted countries' reported statistics, including case fatality rates and the age distribution of cases, due to sampling bias.
Testing is often performed in automated, high-throughput centralized medical laboratories by medical laboratory scientists. Alternatively, point-of-care testing can be done in physician's offices, workplaces or transit hubs.
Selected research
Market Outlook & Growth Opportunities
Global Covid Testing Kit Market Outlook and Growth Opportunities 2026
Market perspective
COVID-19 testing involves analysing samples that indicate the present or past presence of SARS-CoV-2. The two main branches detect either the presence of the virus or antibodies produced in response to infection.
Tests for viral presence are used to diagnose illness and to allow public health authorities to identify and contain outbreaks as quickly as possible. Antibody tests instead support attempts to estimate the prevalence of disease within a population. Another, speculative use is to identify individuals who the antibodies have rendered immune to the disease, although research has yet to confirm that a positive test confers such immunity.
Individual jurisdictions have adopted a broad range of testing protocols. They vary in choosing whom to test, how often to test, analysis protocols, sample collection and the uses of test results. This variation has likely significantly impacted countries' reported statistics, including case fatality rates and the age distribution of cases, due to sampling bias.
Read the full market overview
Testing is often performed in automated, high-throughput centralized medical laboratories by medical laboratory scientists. Alternatively, point-of-care testing can be done in physician's offices, workplaces or transit hubs.
According to our prediction, Asia Pacific is the largest consumer of Covid Testing Kit in global market, with an estimated consumption market share of 69.22% on June.The second place is Europe, following Asia Pacific with the consumption market share of 15.88% on June.
The classification of Covid Testing Kit includes Nucleic Acid Testing and Antibody Testing. The share of Nucleic Acid Testing in the market is 93.05% on June.
The application of Covid Testing Kit includes hospitals and scientific research. In addition, the market share of scientific research is 61.84% on June.
This report provides an overview of the global Covid Testing Kit market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Covid Testing Kit and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Covid Testing Kit revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Covid Testing Kit market.
Covid Testing Kit Segment by Company
Cellex
Abbott
Roche
BioMedomics
BD
Safecare Bio-Tech
Mayo Clinic Laboratories
Chembio Diagnostics
Mount Sinai Laboratory
Ortho Clinical Diagnostics
Zhejiang Orient Gene Biotech
Innovita Biological Technology
Guangzhou Wondfo Biotech
Guangdong Hecin-Scientific
Dynamiker Biotechnology (Tianjin)
ADVAITE
Covid Testing Kit Segment by Type
Nucleic Acid Testing
Antibody Testing
Covid Testing Kit Segment by Application
Hospitals
Scientific Research
Covid Testing Kit Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Covid Testing Kit status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Covid Testing Kit key companies, revenue, market share, and recent developments.
3. To split the Covid Testing Kit breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Covid Testing Kit market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Covid Testing Kit significant trends, drivers, influence factors in global and regions.
6. To analyze Covid Testing Kit competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Covid Testing Kit market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Covid Testing Kit and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Covid Testing Kit.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Covid Testing Kit industry.
Chapter 3: Detailed analysis of Covid Testing Kit company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Covid Testing Kit in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Covid Testing Kit in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Nucleic Acid Testing
- Antibody Testing
Applications
- Hospitals
- Scientific Research
Companies covered
- Cellex
- Abbott
- Roche
- BioMedomics
- BD
- Safecare Bio-Tech
- Mayo Clinic Laboratories
- Chembio Diagnostics
- Mount Sinai Laboratory
- Ortho Clinical Diagnostics
- Zhejiang Orient Gene Biotech
- Innovita Biological Technology
- Guangzhou Wondfo Biotech
- Guangdong Hecin-Scientific
- Dynamiker Biotechnology (Tianjin)
- ADVAITE
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Covid Testing Kit Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Covid Testing Kit Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Covid Testing Kit Market Dynamics
- 2.1 Covid Testing Kit Industry Trends
- 2.2 Covid Testing Kit Industry Drivers
- 2.3 Covid Testing Kit Industry Opportunities and Challenges
- 2.4 Covid Testing Kit Industry Restraints
3 Covid Testing Kit Market by Company
- 3.1 Global Covid Testing Kit Company Revenue Ranking in 2025
- 3.2 Global Covid Testing Kit Revenue by Company (2021-2026)
- 3.3 Global Covid Testing Kit Company Ranking (2024-2026)
- 3.4 Global Covid Testing Kit Company Manufacturing Base and Headquarters
- 3.5 Global Covid Testing Kit Company Product Type and Application
- 3.6 Global Covid Testing Kit Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Covid Testing Kit Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Covid Testing Kit Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Covid Testing Kit Market by Type
- 4.1 Covid Testing Kit Type Introduction
- 4.1.1 Nucleic Acid Testing
- 4.1.2 Antibody Testing
- 4.2 Global Covid Testing Kit Sales Value by Type
- 4.2.1 Global Covid Testing Kit Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Covid Testing Kit Sales Value by Type (2021-2032)
- 4.2.3 Global Covid Testing Kit Sales Value Share by Type (2021-2032)
5 Covid Testing Kit Market by Application
- 5.1 Covid Testing Kit Application Introduction
- 5.1.1 Hospitals
- 5.1.2 Scientific Research
- 5.2 Global Covid Testing Kit Sales Value by Application
- 5.2.1 Global Covid Testing Kit Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Covid Testing Kit Sales Value by Application (2021-2032)
- 5.2.3 Global Covid Testing Kit Sales Value Share by Application (2021-2032)
6 Covid Testing Kit Regional Value Analysis
- 6.1 Global Covid Testing Kit Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Covid Testing Kit Sales Value by Region (2021-2032)
- 6.2.1 Global Covid Testing Kit Sales Value by Region: 2021-2026
- 6.2.2 Global Covid Testing Kit Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Covid Testing Kit Sales Value (2021-2032)
- 6.3.2 North America Covid Testing Kit Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Covid Testing Kit Sales Value (2021-2032)
- 6.4.2 Europe Covid Testing Kit Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Covid Testing Kit Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Covid Testing Kit Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Covid Testing Kit Sales Value (2021-2032)
- 6.6.2 South America Covid Testing Kit Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Covid Testing Kit Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Covid Testing Kit Sales Value Share by Country, 2025 VS 2032
7 Covid Testing Kit Country-level Value Analysis
- 7.1 Global Covid Testing Kit Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Covid Testing Kit Sales Value by Country (2021-2032)
- 7.2.1 Global Covid Testing Kit Sales Value by Country (2021-2026)
- 7.2.2 Global Covid Testing Kit Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Covid Testing Kit Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Covid Testing Kit Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Covid Testing Kit Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Covid Testing Kit Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Covid Testing Kit Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Covid Testing Kit Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Covid Testing Kit Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Covid Testing Kit Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Covid Testing Kit Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Covid Testing Kit Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Covid Testing Kit Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Covid Testing Kit Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Covid Testing Kit Sales Value Growth Rate (2021-2032)
- 7.7.2 France Covid Testing Kit Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Covid Testing Kit Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Covid Testing Kit Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Covid Testing Kit Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Covid Testing Kit Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Covid Testing Kit Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Covid Testing Kit Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Covid Testing Kit Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Covid Testing Kit Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Covid Testing Kit Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Covid Testing Kit Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Covid Testing Kit Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Covid Testing Kit Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Covid Testing Kit Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Covid Testing Kit Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Covid Testing Kit Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Covid Testing Kit Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Covid Testing Kit Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Covid Testing Kit Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Covid Testing Kit Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Covid Testing Kit Sales Value Growth Rate (2021-2032)
- 7.14.2 China Covid Testing Kit Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Covid Testing Kit Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Covid Testing Kit Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Covid Testing Kit Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Covid Testing Kit Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Covid Testing Kit Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Covid Testing Kit Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Covid Testing Kit Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Covid Testing Kit Sales Value Growth Rate (2021-2032)
- 7.17.2 India Covid Testing Kit Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Covid Testing Kit Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Covid Testing Kit Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Covid Testing Kit Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Covid Testing Kit Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Covid Testing Kit Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Covid Testing Kit Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Covid Testing Kit Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Covid Testing Kit Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Covid Testing Kit Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Covid Testing Kit Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Covid Testing Kit Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Covid Testing Kit Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Covid Testing Kit Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Covid Testing Kit Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Covid Testing Kit Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Covid Testing Kit Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Covid Testing Kit Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Covid Testing Kit Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Covid Testing Kit Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Covid Testing Kit Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Covid Testing Kit Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Covid Testing Kit Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Covid Testing Kit Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Covid Testing Kit Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Covid Testing Kit Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Covid Testing Kit Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Covid Testing Kit Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Covid Testing Kit Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Covid Testing Kit Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Covid Testing Kit Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Covid Testing Kit Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Covid Testing Kit Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Covid Testing Kit Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Covid Testing Kit Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Covid Testing Kit Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Covid Testing Kit Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Covid Testing Kit Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Covid Testing Kit Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Covid Testing Kit Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Covid Testing Kit Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Cellex
- 8.1.1 Cellex Company Information
- 8.1.2 Cellex Business Overview
- 8.1.3 Cellex Covid Testing Kit Revenue and Gross Margin (2021-2026)
- 8.1.4 Cellex Covid Testing Kit Product Portfolio
- 8.1.5 Cellex Recent Developments
- 8.2 Abbott
- 8.2.1 Abbott Company Information
- 8.2.2 Abbott Business Overview
- 8.2.3 Abbott Covid Testing Kit Revenue and Gross Margin (2021-2026)
- 8.2.4 Abbott Covid Testing Kit Product Portfolio
- 8.2.5 Abbott Recent Developments
- 8.3 Roche
- 8.3.1 Roche Company Information
- 8.3.2 Roche Business Overview
- 8.3.3 Roche Covid Testing Kit Revenue and Gross Margin (2021-2026)
- 8.3.4 Roche Covid Testing Kit Product Portfolio
- 8.3.5 Roche Recent Developments
- 8.4 BioMedomics
- 8.4.1 BioMedomics Company Information
- 8.4.2 BioMedomics Business Overview
- 8.4.3 BioMedomics Covid Testing Kit Revenue and Gross Margin (2021-2026)
- 8.4.4 BioMedomics Covid Testing Kit Product Portfolio
- 8.4.5 BioMedomics Recent Developments
- 8.5 BD
- 8.5.1 BD Company Information
- 8.5.2 BD Business Overview
- 8.5.3 BD Covid Testing Kit Revenue and Gross Margin (2021-2026)
- 8.5.4 BD Covid Testing Kit Product Portfolio
- 8.5.5 BD Recent Developments
- 8.6 Safecare Bio-Tech
- 8.6.1 Safecare Bio-Tech Company Information
- 8.6.2 Safecare Bio-Tech Business Overview
- 8.6.3 Safecare Bio-Tech Covid Testing Kit Revenue and Gross Margin (2021-2026)
- 8.6.4 Safecare Bio-Tech Covid Testing Kit Product Portfolio
- 8.6.5 Safecare Bio-Tech Recent Developments
- 8.7 Mayo Clinic Laboratories
- 8.7.1 Mayo Clinic Laboratories Company Information
- 8.7.2 Mayo Clinic Laboratories Business Overview
- 8.7.3 Mayo Clinic Laboratories Covid Testing Kit Revenue and Gross Margin (2021-2026)
- 8.7.4 Mayo Clinic Laboratories Covid Testing Kit Product Portfolio
- 8.7.5 Mayo Clinic Laboratories Recent Developments
- 8.8 Chembio Diagnostics
- 8.8.1 Chembio Diagnostics Company Information
- 8.8.2 Chembio Diagnostics Business Overview
- 8.8.3 Chembio Diagnostics Covid Testing Kit Revenue and Gross Margin (2021-2026)
- 8.8.4 Chembio Diagnostics Covid Testing Kit Product Portfolio
- 8.8.5 Chembio Diagnostics Recent Developments
- 8.9 Mount Sinai Laboratory
- 8.9.1 Mount Sinai Laboratory Company Information
- 8.9.2 Mount Sinai Laboratory Business Overview
- 8.9.3 Mount Sinai Laboratory Covid Testing Kit Revenue and Gross Margin (2021-2026)
- 8.9.4 Mount Sinai Laboratory Covid Testing Kit Product Portfolio
- 8.9.5 Mount Sinai Laboratory Recent Developments
- 8.10 Ortho Clinical Diagnostics
- 8.10.1 Ortho Clinical Diagnostics Company Information
- 8.10.2 Ortho Clinical Diagnostics Business Overview
- 8.10.3 Ortho Clinical Diagnostics Covid Testing Kit Revenue and Gross Margin (2021-2026)
- 8.10.4 Ortho Clinical Diagnostics Covid Testing Kit Product Portfolio
- 8.10.5 Ortho Clinical Diagnostics Recent Developments
- 8.11 Zhejiang Orient Gene Biotech
- 8.11.1 Zhejiang Orient Gene Biotech Company Information
- 8.11.2 Zhejiang Orient Gene Biotech Business Overview
- 8.11.3 Zhejiang Orient Gene Biotech Covid Testing Kit Revenue and Gross Margin (2021-2026)
- 8.11.4 Zhejiang Orient Gene Biotech Covid Testing Kit Product Portfolio
- 8.11.5 Zhejiang Orient Gene Biotech Recent Developments
- 8.12 Innovita Biological Technology
- 8.12.1 Innovita Biological Technology Company Information
- 8.12.2 Innovita Biological Technology Business Overview
- 8.12.3 Innovita Biological Technology Covid Testing Kit Revenue and Gross Margin (2021-2026)
- 8.12.4 Innovita Biological Technology Covid Testing Kit Product Portfolio
- 8.12.5 Innovita Biological Technology Recent Developments
- 8.13 Guangzhou Wondfo Biotech
- 8.13.1 Guangzhou Wondfo Biotech Company Information
- 8.13.2 Guangzhou Wondfo Biotech Business Overview
- 8.13.3 Guangzhou Wondfo Biotech Covid Testing Kit Revenue and Gross Margin (2021-2026)
- 8.13.4 Guangzhou Wondfo Biotech Covid Testing Kit Product Portfolio
- 8.13.5 Guangzhou Wondfo Biotech Recent Developments
- 8.14 Guangdong Hecin-Scientific
- 8.14.1 Guangdong Hecin-Scientific Company Information
- 8.14.2 Guangdong Hecin-Scientific Business Overview
- 8.14.3 Guangdong Hecin-Scientific Covid Testing Kit Revenue and Gross Margin (2021-2026)
- 8.14.4 Guangdong Hecin-Scientific Covid Testing Kit Product Portfolio
- 8.14.5 Guangdong Hecin-Scientific Recent Developments
- 8.15 Dynamiker Biotechnology (Tianjin)
- 8.15.1 Dynamiker Biotechnology (Tianjin) Company Information
- 8.15.2 Dynamiker Biotechnology (Tianjin) Business Overview
- 8.15.3 Dynamiker Biotechnology (Tianjin) Covid Testing Kit Revenue and Gross Margin (2021-2026)
- 8.15.4 Dynamiker Biotechnology (Tianjin) Covid Testing Kit Product Portfolio
- 8.15.5 Dynamiker Biotechnology (Tianjin) Recent Developments
- 8.16 ADVAITE
- 8.16.1 ADVAITE Company Information
- 8.16.2 ADVAITE Business Overview
- 8.16.3 ADVAITE Covid Testing Kit Revenue and Gross Margin (2021-2026)
- 8.16.4 ADVAITE Covid Testing Kit Product Portfolio
- 8.16.5 ADVAITE Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst